Engelson Erik T. - 15 Sep 2022 Form 4 Insider Report for Lucira Health, Inc.

Role
President and Chief Executive, Director
Signature
/s/ Dan George, Attorney-in-Fact for Erik T. Engelson
Issuer symbol
N/A
Transactions as of
15 Sep 2022
Net transactions value
+$36,400
Form type
4
Filing time
19 Sep 2022, 14:34:04 UTC
Previous filing
17 Jun 2022
Next filing
13 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LHDXQ Common Stock Purchase $36,400 +20,000 +32% $1.82* 83,282 15 Sep 2022 Direct
holding LHDXQ Common Stock 46,400 15 Sep 2022 See Footnotes F1
holding LHDXQ Common Stock 191,705 15 Sep 2022 See Footnotes F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares are held by the Elizabeth North Engelson Trust, dated January 17, 2001, for which Mr. Engelson serves as trustee.
F2 The shares are held by Epic Pacific, LLC, of which Mr. Engelson is a Member. Mr. Engelson disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.